Eli Lilly (LLY) stock fell as its obesity therapy tirzepatide missed forecasts, amid focus on compounded weight loss drugmaker Hims & Hers
https://seekingalpha.com/news/4394979-hims-hers-stock-up-eli-lilly-glp-1-sales-miss
Eli Lilly (LLY) stock fell as its obesity therapy tirzepatide missed forecasts, amid focus on compounded weight loss drugmaker Hims & Hers
https://seekingalpha.com/news/4394979-hims-hers-stock-up-eli-lilly-glp-1-sales-miss
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.